Pharvaris N.V.
PHVS
DELAYED 1 MONTH
15 insider filings · Latest: Jun 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 8 6:53 PM | Anna NijdamPrincipal Accounting Officer | Sale | 2,670 | $30.87 | $82.4K | 46,275(D) | View → |
| May 21, 2026 | May 26 9:53 PM | Viviane MongesDirector | Sale | 9,667 | $30.29 | $292.9K | 5,500(D) | View → |
| May 22, 2026 | May 26 9:45 PM | Anna NijdamPrincipal Accounting Officer | Sale | 5,501 | $30.74 | $169.1K | 48,945(D) | View → |
| May 21, 2026 | May 26 9:45 PM | Anna NijdamPrincipal Accounting Officer | Sale | 1,829 | $30.60 | $56.0K | 48,945(D) | View → |
| May 21, 2026 | May 26 9:42 PM | David W. NassifCFO / CLO | Sale | 10,000 | $30.31 | $303.1K | 120,300(D) | View → |
| May 20, 2026 | May 22 6:54 PM | Elisabeth BjorkDirector | Sale | 10,000 | $29.32 | $293.2K | 15,167(D) | View → |
| May 18, 2026 | May 20 9:33 PM | Berndt ModigDirector, Chief Executive Officer | Sale | 2,292 | $29.22 | $67.0K | 137,500(D) | View → |
| May 15, 2026 | May 19 10:48 PM | Robert GlassmanDirector | Sale | 10,000 | $29.82 | $298.2K | 10,500(D) | View → |
| May 15, 2026 | May 19 10:44 PM | Stefan Andreas AbeleChief Technical Ops Officer | Sale | 8,748 | $29.82 | $260.9K | 35,194(D) | View → |
| May 15, 2026 | May 19 10:42 PM | Wim SouverijnsChief Commercial Officer | Sale | 10,000 | $29.92 | $299.2K | 45,111(D) | View → |
| May 1, 2026 | May 5 7:51 PM | Peng LuChief Medical Officer | Sale | 14,166 | $30.17 | $427.4K | 66,083(D) | View → |
| Apr 30, 2026 | May 1 11:32 PM | Johannes Gerardus Christiaan Petrus SchikanDirector | Sale | 29,070 | $30.32 | $881.4K | 355,167(D) | View → |
| Apr 29, 2026 | May 1 11:32 PM | Johannes Gerardus Christiaan Petrus SchikanDirector | Sale | 3,830 | $30.07 | $115.2K | 384,237(D) | View → |
| Apr 30, 2026 | May 1 11:30 PM | Anne LesageChief Early Development | Sale | 40,900 | $30.26 | $1.2M | 133,969(I) | View → |
| Apr 29, 2026 | May 1 11:30 PM | Anne LesageChief Early Development | Sale | 7,400 | $30.07 | $222.5K | 153,169(I) | View → |
| Apr 30, 2026 | May 1 11:09 PM | Peng LuChief Medical Officer | Sale | 15,000 | $30.24 | $453.6K | 66,083(D) | View → |
| Apr 29, 2026 | May 1 11:09 PM | Peng LuChief Medical Officer | Sale | 3,733 | $30.06 | $112.2K | 62,350(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | May 26 9:45 PM | Anna NijdamPrincipal Accounting Officer | Option Exercise | 5,501 | $20.00 | 22,670(D) | View → |
| May 21, 2026 | May 26 9:45 PM | Anna NijdamPrincipal Accounting Officer | Option Exercise | 1,829 | $20.00 | 28,171(D) | View → |
| May 20, 2026 | May 22 6:54 PM | Elisabeth BjorkDirector | Option Exercise | 10,000 | $8.05 | 11,000(D) | View → |
| May 15, 2026 | May 19 10:48 PM | Robert GlassmanDirector | Option Exercise | 5,333 | $22.31 | 8,667(D) | View → |
| May 1, 2026 | May 5 7:51 PM | Peng LuChief Medical Officer | Option Exercise | 14,166 | $2.59 | 205,308(D) | View → |
| Apr 30, 2026 | May 1 11:30 PM | Anne LesageChief Early Development | Option Exercise | 21,700 | $8.05 | 82,000(D) | View → |
| Apr 29, 2026 | May 1 11:30 PM | Anne LesageChief Early Development | Option Exercise | 3,700 | $2.59 | 12,772(D) | View → |
| Apr 30, 2026 | May 1 11:09 PM | Peng LuChief Medical Officer | Option Exercise | 15,000 | $2.59 | 219,474(D) | View → |
| Apr 29, 2026 | May 1 11:09 PM | Peng LuChief Medical Officer | Option Exercise | 3,733 | $2.59 | 234,474(D) | View → |